Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 409

2.
4.
6.

The herpes simplex virus type 1 (HSV-1) regulatory protein ICP0 interacts with and Ubiquitinates p53.

Boutell C, Everett RD.

J Biol Chem. 2003 Sep 19;278(38):36596-602. Epub 2003 Jul 9.

7.

A RING finger ubiquitin ligase is protected from autocatalyzed ubiquitination and degradation by binding to ubiquitin-specific protease USP7.

Canning M, Boutell C, Parkinson J, Everett RD.

J Biol Chem. 2004 Sep 10;279(37):38160-8. Epub 2004 Jul 6.

8.
10.
12.

Topors functions as an E3 ubiquitin ligase with specific E2 enzymes and ubiquitinates p53.

Rajendra R, Malegaonkar D, Pungaliya P, Marshall H, Rasheed Z, Brownell J, Liu LF, Lutzker S, Saleem A, Rubin EH.

J Biol Chem. 2004 Aug 27;279(35):36440-4. Epub 2004 Jul 9.

13.
14.
15.

Functional characterization of residues required for the herpes simplex virus 1 E3 ubiquitin ligase ICP0 to interact with the cellular E2 ubiquitin-conjugating enzyme UBE2D1 (UbcH5a).

Vanni E, Gatherer D, Tong L, Everett RD, Boutell C.

J Virol. 2012 Jun;86(11):6323-33. doi: 10.1128/JVI.07210-11. Epub 2012 Mar 21.

16.

Herpes simplex virus type 1 ICP0 phosphorylation mutants impair the E3 ubiquitin ligase activity of ICP0 in a cell type-dependent manner.

Boutell C, Everett R, Hilliard J, Schaffer P, Orr A, Davido D.

J Virol. 2008 Nov;82(21):10647-56. doi: 10.1128/JVI.01063-08. Epub 2008 Aug 20.

17.
19.

The stability of herpes simplex virus 1 ICP0 early after infection is defined by the RING finger and the UL13 protein kinase.

Zhu Z, Du T, Zhou G, Roizman B.

J Virol. 2014 May;88(10):5437-43. doi: 10.1128/JVI.00542-14. Epub 2014 Feb 26.

Supplemental Content

Support Center